Bellevue Life Sciences Acquisition (BLACR) Institutional Ownership

$0.15
0.00 (0.00%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for Bellevue Life Sciences Acquisition (NASDAQ:BLACR)

Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$149.76K
Number of
Institutional Sellers
(last 12 months)
0
Get BLACR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bellevue Life Sciences Acquisition stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Bellevue Life Sciences Acquisition Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/31/2023 Spartan Fund Management Inc.200,000$46K0.0%N/A0.000%
5/11/2023Highbridge Capital Management LLC576,469$104K0.0%N/A0.000%
(Data available from 1/1/2016 forward)

BLACR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BLACR shares?

During the previous two years, the following institutional investors and hedge funds held shares of Bellevue Life Sciences Acquisition shares: Highbridge Capital Management LLC ($104K), Spartan Fund Management Inc. ($46K).Learn more on BLACR's institutional investors.

Which institutional investors have been buying Bellevue Life Sciences Acquisition stock?

The following institutional investors have purchased Bellevue Life Sciences Acquisition stock in the last 24 months: Highbridge Capital Management LLC ($576.47K), and Spartan Fund Management Inc. ($200K).

How much institutional buying is happening at Bellevue Life Sciences Acquisition?

Institutional investors have bought a total of 776,469 shares in the last 24 months. This purchase volume represents approximately $149.76K in transactions.


This page (NASDAQ:BLACR) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners